Role of polyamines in arginine-dependent colon carcinogenesis in Apc Min/+ mice

Molecular Carcinogenesis

Volumn 45, Issue 10, 2006, Pages 764-773

  Yerushalmi, Hagit F ^a   Besselsen, David G ^b   Ignatenko, Natalia A ^c   Blohm Mangone, Karen A ^a   Padilla Torres, Jose L ^a   Stringer, David E ^a   Guillen, Jose M ^a   Holubec, Hana ^c   Payne, Claire M ^c   Gerner, Eugene W ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Arginine; D,L diflouromethylornithine (DFMO); Intestinal and colonic carcinogenesis; Min mice; Polyamines

Indexed keywords

ARGININE; EFLORNITHINE; ORNITHINE; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; COLON CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME SUBSTRATE; INTESTINE TUMOR; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; TUMOR VOLUME;

ANIMAL FEED; ANIMALS; APOPTOSIS; ARGININE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; INTESTINAL ABSORPTION; MICE; MICE, INBRED C57BL; POLYAMINES;

MURINAE;

EID: 33749251088     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20246     Document Type: Article

References (36)

1. Wallace HM. The physiological role of the polyamines. Eur J Clin Invest 2000;30:1-3.
2. Cohen SS. A guide to the polyamines. New York: Oxford University Press, Inc.; 1998.
3. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003;7:113-126.
4. Janne J, Alhonen L, Pietila M, Keinanen TA. Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem 2004;271:877-894.
5. Feith DJ, Shantz LM, Pegg AE. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res 2001;61:6073-6081.
6. Fong LY, Feith DJ, Pegg AE. Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res 2003;63:3945-3954.
7. Milovic V, Turchanowa L. Polyamines and colon cancer. Biochem Soc Trans 2003;31:381-383.
8. Weiss TS, Bernhardt G, Buschauer A, et al. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade. Int J Colorectal Dis 2002;17:381-387.
9. Fultz KE, Gerner EW. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol Carcinog 2002;34:10-18.
10. Nilsson JA, Keller UB, Baudino TA, et al. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 2005;7:433-444.
11. Lawson KR, Ignatenko NA, Piazza GA, Cui H, Gerner EW. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 2000;9:1155-1162.
12. Erdman SH, Ignatenko NA, Powell MB, et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 1999;20:1709-1713.
13. Byers TL, Pegg AE. Properties and physiological function of the polyamine transport system. Am J Physiol 1989;257: C545-C553.
14. Meyskens FL, Jr., Gerner EW. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999;5:945-951.
15. Gerner EW, Meyskens FL. Polyamines and cancer: Old molecules, new understanding. Nature Rev Cancer 2004;4: 781-792.
16. Yerushalmi HF, Besselsen DG, Ignatenko NA, et al. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinog 2006;45:93-105.
17. Ha HC, Woster PM, Yager JD, Casero RA Jr. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci USA 1997:94: 11557-11562.
18. Babbar N, Ignatenko NA, Casero RA Jr, Gerner EW. Cyclooxygenase- independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem 2003;278:47762-47775.
19. Stefanelli C, Tantini B, Fattori M, et al. Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett 2002;527:223-228.
20. Stefanelli C, Bonavita F, Stanic I, et al. Spermine triggers the activation of caspase-3 in a cell-free model of apoptosis. FEBS Lett 1999;451:95-98.
21. Hawk CT, Leary SL, Morris TH. Formula for laboratory animals. Ames: Blackwell Publishing; 2005.
22. Venho B, Voutilainen S, Valkonen VP, et al. Arginine intake, blood pressure, and the incidence of acute coronary events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2002;76:359-364.
23. Gibson SL, Dai CY, Lee HW, et al. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Res 2003;63:742-746.
24. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-777.
25. Seiler N, Knodgen B. High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J Chromatogr 1980;221:227-235.
26. Halmekyto M, Alhonen L, Wahlfors J, Sinervirta R, Eloranta T, Janne J. Characterization of a transgenic mouse line overexpressing the human ornithine decarboxylase gene. Biochem J 1991;278:895-898.
27. Heljasvaara R, Veress I, Halmekyto M, et al. Transgenic mice overexpressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homoeostasis in their tissues. Biochem J 1997;323:457-462.
28. Roy HK, Gulizia J, DiBaise JK, et al. Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice. Cancer Lett 2004;215:35-42.
29. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998;85:742-750.
30. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001;2:149-156.
31. Payne CM, Bernstein C, Bernstein H, Gerner EW, Garewal H. Reactive nitrogen species in colon carcinogenesis. Antioxid Redox Signal 1999;1:449-467.
32. Payne CM, Waltmire CN, Crowley C, et al. Caspase-6 mediated cleavage of guanylate cyclase alpha 1 during deoxycholate-induced apoptosis: Protective role of the nitric oxide signaling module. Cell Biol Toxicol 2003;19: 373-392.
33. Meyskeris FL, Jr., Emerson SS, Pelot D, et al. Dose deescalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994; 86:1122-1130.
34. Jacoby RF, Cole CE, Tutsch K, et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res 2000;60:1864-1870.
35. Paulsen JE, Reistad R, Eliassen KA, Sjaastad OV, Alexander J. Dietary polyamines promote the growth of azoxymethane-induced aberrant crypt foci in rat colon. Carcinogenesis 1997;18:1871-1875.
36. Sarhan S, Knodgen B, Seiler N. The gastrointestinal tract as polyamine source for tumor growth. Anticancer Res 1989;9: 215-223.